Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 25 Issue 2, February 2017

News and Commentary

    • Detlef Bockenhauer
    • Robert Kleta
    News and Commentary

    Advertisement

Top of page ⤴

Policy

Top of page ⤴

Letter

Top of page ⤴

Article

Top of page ⤴

Short Report

Top of page ⤴

Clinical Utility Gene Card

  • 1. Name of the disease (synonyms)

    Deficiency of UDP-galactose:O-beta-d-xylosylprotein 4-d-galactosyltransferase, deficiency of xylosylprotein 4-beta-galactosyltransferase, polypeptide 7, deficiency of galactosyltransferase I, B4GALT7 deficiency, B4GALT7-CDG, progeroid form of Ehlers–Danlos syndrome, type 1, Ehlers–Danlos syndrome with short stature and limb anomalies, Larsen of Reunion Island syndrome.

    2. OMIM# of the disease

    130070.

    3. Name of the analysed genes or DNA/chromosome segments

    B4GALT7.

    4. OMIM# of the gene(s)

    604327.

    Review of the analytical and clinical validity as well as of the clinical utility of DNA-based testing for mutations in B4GALT7 in diagnostic, predictive and prenatal settings, and for risk assessment in relatives.

    • Jaak Jaeken
    • Dirk J Lefeber
    • Gert Matthijs
    Clinical Utility Gene Card
  • 1. Name of the disease (synonyms)

    16p12.1 microdeletion syndrome (hg18/NCBI36). Updated release of the human reference genome (hg19/GRCh37) annotates this region as 16p12.2.

    2. OMIM# of the disease

    136570.

    3. Name of the analysed genes or DNA/chromosome segments

    Chromosome 16p12.2 (hg19 chr16:g.(?_ 21950000)_(22470000_?)del).

    4. OMIM# of the gene(s)

    UQCRC2 (*191329); EEF2K (*606968); CDR2 (*117340); PDZD9 (no OMIM entry); C16orf52 (no OMIM entry); VWA3A (no OMIM entry); and POLR3E (no OMIM entry).

    Review of the analytical and clinical validity as well as of the clinical utility of DNA-based testing for mutations in the 16p12.2 region in diagnostic, predictive and prenatal settings, and for risk assessment in relatives.

    • Lucilla Pizzo
    • Joris Andrieux
    • Santhosh Girirajan
    Clinical Utility Gene Card
Top of page ⤴

Search

Quick links